Article
ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators, Fourth Edition
ANDA Litigation
Authors
-
- Name
- Person title
- Principal
-
- Name
- Person title
- Associate
Biosimilars are transforming the pharmaceutical market, but their road to commercialization is anything but straightforward. In Chapter 6 of ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators (4th ed.), attorneys Louis Fogel and Yun Dong offer a comprehensive look at the evolving battlegrounds of biologics litigation.
The chapter unpacks the unique framework of the Biologics Price Competition and Innovation Act, including the highly choreographed “patent dance,” and provides analysis of key decisions that are shaping the field. It also explores how antitrust scrutiny is intensifying as brand manufacturers deploy creative strategies to defend their market share.
Learn more about the full edition: ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators, Fourth Edition
The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.